Correlation Between Zura Bio and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zura Bio and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and NextCure, you can compare the effects of market volatilities on Zura Bio and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and NextCure.

Diversification Opportunities for Zura Bio and NextCure

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Zura and NextCure is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Zura Bio i.e., Zura Bio and NextCure go up and down completely randomly.

Pair Corralation between Zura Bio and NextCure

Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the NextCure. In addition to that, Zura Bio is 1.2 times more volatile than NextCure. It trades about -0.2 of its total potential returns per unit of risk. NextCure is currently generating about 0.0 per unit of volatility. If you would invest  82.00  in NextCure on November 3, 2024 and sell it today you would lose (1.52) from holding NextCure or give up 1.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Zura Bio Limited  vs.  NextCure

 Performance 
       Timeline  
Zura Bio Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Zura Bio and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zura Bio and NextCure

The main advantage of trading using opposite Zura Bio and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Zura Bio Limited and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk